Kiyatec | Revolutionizing Cancer Care
Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.
Our Mission - Kiyatec | About Us
To date, Kiyatec has been awarded more than $5 million of competitively awarded federal funding, including contracts from the National Cancer Institute, cultivated clinical collaborations at leading national cancer institutions, and built productive relationships with premier biopharmaceutical companies developing the cancer therapies of the ...
Kiyatec Inc. - LinkedIn
Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create...
Kiyatec | COLAAB
Kiyatec specializes in 3D cell culture models and predictive analytics to evaluate drug response and treatment outcomes. Their proprietary 3D cell culture technology cultivates patients' live tumor cells in a controlled environment that closely …
Healthcare Professionals | Kiyatec
Learn how 3D Predict can benefit healthcare professionals and their patients by helping predict therapeutic response for cancer treatment.
KIYATEC - KIYATEC Inc. Trademark Registration - US Patent and …
Trademark registration for KIYATEC Inc.. The mark consists of a series of seven balls arranged in a circular fashion three of which are connected to the right of which appears the word
KIYATEC | Upstate Upstarts
KIYATEC is a functional precision oncology company that measures the response of individual patient live cancer cells with its 3D cell culture technology.
Kiyatec - Biotech Careers
KIYATEC is modeling and predicting cancer patient response to drug therapies, using ex vivo 3D cell culture technology, of live cancer cells derived from surgical or biopsy tissue, in order to inform clinical decision making and drive drug development.
KIYATEC Company Profile - Office Locations, Competitors ... - Craft
KIYATEC is a company specializing in oncology treatment. It uses ex vivo 3D cell culture technology platform to model and predict response to approved and investigational cancer drugs targeting a spectrum of solid tumors.
KIYATEC - Crunchbase Company Profile & Funding
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co‐culture ...